NCT04305145 2026-01-29
Infliximab for Treatment of Immune Checkpoint Inhibitor Colitis
Massachusetts General Hospital
Phase 2 Active not recruiting
Clinical Trials
5 trialsNCT05034536 2026-01-08
PD-1 Antibody Therapy + Infliximab for Metastatic Melanoma
Massachusetts General Hospital
Phase 2 Active not recruiting
NCT06136546 2025-05-07
Cognitive Dysfunction and Inflammation in Depression: Experimental Inhibition Via Infliximab
Massachusetts General Hospital
Phase 2 Recruiting
NCT00112749 2020-07-31
Infliximab in Treating Cancer-Related Fatigue in Postmenopausal Women Who Have Undergone Treatment for Breast Cancer
Jonsson Comprehensive Cancer Center
Phase 2 Terminated
NCT02457585 2017-05-15
Clinical Study of Anti-tumor Necrosis Factor Therapy in Patients With Takayasu Arteritis
Seoul National University Hospital
Phase 2 Unknown